Results 1 to 10 of about 314 (69)

The nose is not enough: Multi‐site sampling is best for MRSP detection in dogs and households

open access: yesVeterinary Dermatology, Volume 33, Issue 6, Page 576-580, December 2022., 2022
Abstract Background Following recovery from meticillin‐resistant Staphylococcus pseudintermedius (MRSP) infection of any type, dogs may continue to carry MRSP asymptomatically on skin and mucosae, contributing to the spread of this multidrug‐resistant, veterinary hospital‐associated pathogen with zoonotic potential to others and into the environment ...
Sian‐Marie Frosini   +3 more
wiley   +1 more source

Nonalcoholic fatty liver disease in relation to the remission and progression along the glycemic continuum 非酒精性脂肪性肝病与血糖的缓解和进展

open access: yesJournal of Diabetes, Volume 14, Issue 9, Page 606-619, September 2022., 2022
Highlights To what extent NAFLD is associated with glycemic remission among the general population remains unclear. The study elaborated that presence of NAFLD and fibrosis status decreased the chance of glycemic remission whereas NAFLD improvement mitigated glycemic deterioration, emphasizing joint management to liver‐focused subgroups of diabetes ...
Zhuojun Xin   +15 more
wiley   +1 more source

DUAL I China: Improved glycemic control with IDegLira versus its individual components in a randomized trial with Chinese participants with type 2 diabetes uncontrolled on oral antidiabetic drugs DUAL I China:在一项对未服用口服降糖药物的中国2型糖尿病患者进行的随机试验中, IDegLira与其单独成分相比改善了血糖控制

open access: yesJournal of Diabetes, Volume 14, Issue 6, Page 401-413, June 2022., 2022
Highlights Insulin degludec/liraglutide (IDegLira) has good efficacy and tolerability in Chinese adults with type 2 diabetes not controlled on oral antidiabetic drugs. IDegLira provides the clinical advantages of insulin and glucagon‐like peptide 1 receptor agonists, improving glycemic control while reducing the main adverse effects of insulin (weight ...
Weiqing Wang   +11 more
wiley   +1 more source

Evaluation of the effects of chlorhexidine digluconate with and without cBD103 or cCath against multidrug‐resistant clinical isolates of Staphylococcus pseudintermedius

open access: yesVeterinary Dermatology, Volume 33, Issue 1, Page 17-e6, February 2022., 2022
Background – Because of the increased incidence of multidrug‐resistant (MDR) bacteria, the use of disinfectants over antibiotics has been encouraged. However, the interactions between disinfectants and host local immunity are poorly understood. Objective – To assess the effects of chlorhexidine digluconate (Chx), with and without selected host defence ...
Domenico Santoro   +3 more
wiley   +1 more source

A novel therapeutic diet can significantly reduce the medication score and pruritus of dogs with atopic dermatitis during a nine‐month controlled study

open access: yesVeterinary Dermatology, Volume 33, Issue 1, Page 55-e18, February 2022., 2022
Background – Canine atopic dermatitis (cAD) is a common chronic relapsing pruritic skin disease for which management commonly relies on life‐long use of immunomodulatory drugs. A number of the medications used are associated with adverse effects and the potential for complications during long‐term use.
Adrian Watson   +3 more
wiley   +1 more source

Whole genome sequencing and de novo assembly of Staphylococcus pseudintermedius: a pangenome approach to unravelling pathogenesis of canine pyoderma

open access: yesVeterinary Dermatology, Volume 32, Issue 6, Page 654-663, December 2021., 2021
Background Staphylococcus pseudintermedius is the main aetiological agent of canine pyoderma. Whole genome sequencing is the most comprehensive way of obtaining relevant genomic information about micro‐organisms. Hypothesis/Objectives Oxford Nanopore technology enables quality sequencing and de novo assembly of the whole genome of S.
Lluís Ferrer   +13 more
wiley   +1 more source

Chemical and microbiological stability of diluted ceftazidime in three different solutions under three storage temperatures over a 28 day period

open access: yesVeterinary Dermatology, Volume 32, Issue 5, Page 456-e124, October 2021., 2021
Background – Ceftazidime (CAZ) solutions are being used based on anecdotal reports for otitis externa complicated by multidrug‐resistant Pseudomonas aeruginosa (MDR PA). The chemical and microbiological stability of these proposed compounded solutions have not been evaluated, and likely are affected by the diluent and storage duration or temperature ...
Sarah E. Hoff   +4 more
wiley   +1 more source

神经内科重症患者多重耐药菌感染危险因素分析

open access: yesZhongguo shiyan zhenduanxue, 2021
研究发现,神经内科病区、医院的重症监护病房(ICU)以及神经外科病区等,病原菌耐药率相较于医院病原菌的整体耐药水平要高出许多,与此同时,其高耐药性与多重耐药性(MDROs)等特征也较为明显,在医院多重耐药菌检出率科室中位居前列[1]。在治疗过程中侵入性操作增加了医院多重耐药菌感染的风险[2]。多重耐药菌的流行增加了不良临床结果的发生率,延长了住院时间,提高了医疗成本。因此,降低神经内科重症住院患者多重耐药菌感染的发生率,提高患者的生活质量,已成为临床医护人员重点关注的问题[3 ...
南鹤, 蔡媛媛, 黄丹
doaj  

水貂源致病性大肠杆菌对喹诺酮类药物耐药表型与耐药基因型检测与分析

open access: yes野生动物学报, 2021
为了分析水貂源致病性大肠杆菌对喹诺酮类药物耐药表型与耐药基因型相关性,采用KB药敏纸片法和PCR法分别检测临床分离的15株水貂源致病性大肠杆菌耐药性与耐药表型。结果表明,15株水貂源致病性大肠杆菌对恩诺沙星、诺氟沙星、氧氟沙星、环丙沙星耐药率为467%—267%,呈现多重耐药性;耐药基因gyrA、gyrB 、qnrA、pare、qnrB检出率为80%—100%,其他耐药基因检出率为7%—40%,呈现多种耐药基因型;恩诺沙星、诺氟沙星、氧氟沙星、环丙沙星耐药表型与耐药基因gyrA、gyrB ...
郭家媚 1 葛成 1 张文斌 1 吴同垒 1 张志强 1 贾青辉 1 张召兴 1   +1 more
doaj  

牛粪沼渣中多重耐药细菌的环境风险

open access: yesShuitu Baochi Xuebao, 2023
为研究牛粪厌氧发酵沼渣中多重耐药细菌的环境污染风险,选用畜禽养殖中常用的5种抗生素(红霉素、氨苄青霉素、金霉素、链霉素、环丙沙星)对牛粪沼渣中可培养抗生素抗性细菌进行筛选。结果表明:多重耐药细菌的比例高达76.5%,其中,抗5种和4种抗生素的细菌分别有11,21株。所有多重耐药细菌均对氨苄青霉素具有抗性,抗红霉素、金霉素和链霉素的细菌分别占总多重耐药细菌数的92.0%,89.3%,61.3%。通过细菌16S rRNA测序鉴定,32株具有4种以上抗性的细菌分别属于福氏志贺氏菌、摩根氏菌和假中间苍白杆菌 ...
胡涛   +8 more
doaj  

Home - About - Disclaimer - Privacy